Australia's most trusted
source of pharma news
Posted 2 July 2026 AM
The TGA is seeking stakeholder's feedback on the regulation of radiopharmaceuticals in Australia, with interested parties given until the end of this month to make a submission.
The consultation is intended to discern stakeholder's actual experiences with existing regulatory pathways, exemptions, and access mechanisms concerning the new type of treatments. It doesn't cover funding of the treatments, but will accept high level feedback on how reimbursement interacts with regulatory pathways in practice.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.